Nathalie Cretin

Everolimus versus Mycophenolate Mofetil in the Prevention of Rejection in De Novo Renal Transplant Recipients: A 3-Year Randomized, Multicenter, Phase III Study

S. Mulgaonkar, H. Sollinger, R. Mendez, 2005, Transplantation.

Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6‐Month Safety and Efficacy Results of Two Randomized Studies

Julio Pascual, Peter Bernhardt, Giovanni Civati, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years.

A. Yeung, E. Tuzcu, J. Tobis, 2005, Journal of the American College of Cardiology.

Everolimus (Certican) 12-Month Safety and Efficacy Versus Mycophenolate Mofetil in de Novo Renal Transplant Recipients

Raimund Margreiter, W. Weimar, A. Jappe, 2004, Transplantation.